Predict your next investment

Clover Biopharmaceuticals company logo
HEALTHCARE | Biotechnology
cloverbiopharma.com

See what CB Insights has to offer

Business Relationships

5

Service Providers

1

Clover Biopharmaceuticals Service Providers

1 Service Provider

Clover Biopharmaceuticals has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Series B

Other

Accounting Consultant

Service Provider

Associated Rounds

Series B

Provider Type

Other

Service Type

Accounting Consultant

Partnership data by VentureSource

Clover Biopharmaceuticals Partners & Customers

5 Partners and customers

Clover Biopharmaceuticals has 5 strategic partners and customers. Clover Biopharmaceuticals recently partnered with Dynavax Technologies Corporation on June 6, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

6/30/2021

Licensor

Dynavax Technologies Corporation

United States

Clover And Dynavax Announce Commercial Supply Agreement Of Dynavax's CpG 1018 Adjuvant For Clover's COVID-19 Vaccine Candidate

Ryan Spencer , Chief Executive Officer of Dynavax Technologies Corporation commented , `` Dynavax Technologies Corporation is excited for the opportunity to expand our partnership with Clover Biopharmaceuticals into an important commercial supply agreement to provide significant amounts of CpG 1018 for combatting the ongoing pandemic .

5

6/19/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

3/24/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

2/24/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

2/24/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

6/30/2021

6/19/2020

3/24/2020

2/24/2020

2/24/2020

Type

Licensor

Partner

Partner

Partner

Partner

Business Partner

Dynavax Technologies Corporation

Country

United States

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Clover And Dynavax Announce Commercial Supply Agreement Of Dynavax's CpG 1018 Adjuvant For Clover's COVID-19 Vaccine Candidate

Ryan Spencer , Chief Executive Officer of Dynavax Technologies Corporation commented , `` Dynavax Technologies Corporation is excited for the opportunity to expand our partnership with Clover Biopharmaceuticals into an important commercial supply agreement to provide significant amounts of CpG 1018 for combatting the ongoing pandemic .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.